Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

CB Therapeutics hires new business development lead

By Brian Buntz | June 23, 2022

CB TherapeuticsThe biosynthesis company CB Therapeutics has named Tiffany Hurd as its new business development lead.

At Carlsbad, California-based CB Therapeutics, Hurd will help forge partnerships with organizations that will benefit the company’s sustainability, value propositions and longevity.

Hurd has more than 14 years of experience working in senior neurology and neuroscience positions at Fortune 500 companies and more than four years of experience working with consulting teams, psychedelic companies and coaching individual clients.

CB Therapeutics partners with companies in the psychedelic, cannabinoid and food tech industries on the creation of biosynthetic compounds.

A press release from the company notes that Hurd will help build a bridge between the traditional pharmaceutical market and the nascent psychedelic drug discovery market.

“I think there’s so much opportunity for the company to continue to grow in many different ways,” Hurd said in a press statement. “I can even see a space where, you know, I’m coming in as the first business development lead and, and then, you know, over time developing and leading a team.”


Filed Under: Drug Discovery and Development
Tagged With: CB Therapeutics
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Pfizer-BioNTech
Pfizer and BioNTech forge new COVID-19 vaccine deal with U.S. government
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
GSK
GSK to invest £1 billion on infectious disease research
Pharma 50
2022 Pharma 50: The 50 largest pharmaceutical companies 

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50